Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Video

ecancer's extensive video archive features interviews, panel discussions and conference coverage on almost every topic in oncology.

New epigenetic targets and the role of DNA methylation fingerprints in cancer treatment

Prof Manuel Esteller - University of Barcelona, Catalonia, Spain

New epigenetic targets and the role of DNA methylation fingerprints in cancer treatment ( Prof Manuel Esteller - University of Barcelona, Catalonia, Spain )

Highlights from day two of the 5th International Workshop

Prof Gareth Morgan (Chair) - Institute of Cancer Research, Sutton, UK; Prof Keith Stewart - Mayo Clinic, Arizona, USA; Prof Kenneth Anderson - Dana-Farber Cancer Institute Boston, MA

Highlights from day two of the 5th International Workshop ( Prof Gareth Morgan (Chair) - Institute of Cancer Research, Sutton, UK; Prof Keith Stewart - Mayo Clinic, Arizona, USA; Prof Kenneth Anderson - Dana-Farber Cancer Institute Boston, MA )

Highlights from day one of the 5th International Workshop

Prof Gareth Morgan (Chair) - Institute of Cancer Research, Sutton, UK; Prof Keith Stewart - Mayo Clinic, Arizona, USA; Prof Kenneth Anderson - Dana-Farber Cancer Institute Boston, MA

Highlights from day one of the 5th International Workshop ( Prof Gareth Morgan (Chair) - Institute of Cancer Research, Sutton, UK; Prof Keith Stewart - Mayo Clinic, Arizona, USA; Prof Kenneth Anderson - Dana-Farber Cancer Institute Boston, MA )

2011 St Gallen Consensus breast cancer recommendations

Prof Richard Gelber - Dana-Farber Cancer Institute, Boston, USA; Prof Aron Goldhirsch – European Institute of Oncology, Milan

2011 St Gallen Consensus breast cancer recommendations ( Prof Richard Gelber - Dana-Farber Cancer Institute, Boston, USA; Prof Aron Goldhirsch – European Institute of Oncology, Milan )

Sarcoma UK: providing patient support and funding sarcoma research

Roger Wilson - Sarcoma UK, London, UK

Sarcoma UK: providing patient support and funding sarcoma research ( Roger Wilson - Sarcoma UK, London, UK )

Smaller, faster clinical trials

Dr Marie-Cecile Le Deley - Institut Gustave-Roussy, Villejuif, France

Smaller, faster clinical trials ( Dr Marie-Cecile Le Deley - Institut Gustave-Roussy, Villejuif, France )

Evolving landscape in castration-resistant prostate cancer

Dr Per-Anders Abrahamsson - Lund University, Sweden; Dr Chris Parker - Royal Marsden Cancer Center, London, UK

Evolving landscape in castration-resistant prostate cancer ( Dr Per-Anders Abrahamsson - Lund University, Sweden; Dr Chris Parker - Royal Marsden Cancer Center, London, UK )

Opportunities for young oncologists attending EMCC 2011

Dr Katherina Farr - Aarhus University Hospital, Denmark

Opportunities for young oncologists attending EMCC 2011 ( Dr Katherina Farr - Aarhus University Hospital, Denmark )

Key benefits of the European Multidisciplinary Cancer Congress

Dr Karin Tamas - Szent Laszlo Teaching Hospital, Budapest, Hungary

Key benefits of the European Multidisciplinary Cancer Congress ( Dr Karin Tamas - Szent Laszlo Teaching Hospital, Budapest, Hungary )

Multidisciplinary cancer care and importance of patient involvement

Prof José Mariano Gago - Instituto Superior Tecnico, Lisbon, Portugal

Multidisciplinary cancer care and importance of patient involvement ( Prof José Mariano Gago - Instituto Superior Tecnico, Lisbon, Portugal )

A new light activated technique for delivery of anti-cancer drugs

Dr Pål Selbo - Oslo University Hospital and PCI Biotech, Norway

A new light activated technique for delivery of anti-cancer drugs ( Dr Pål Selbo - Oslo University Hospital and PCI Biotech, Norway )

President of ECCO on EMCC 2011

Prof Michael Baumann, President of the European CanCer Organisation, Brussels, Belgium

President of ECCO on EMCC 2011 ( Prof Michael Baumann, President of the European CanCer Organisation, Brussels, Belgium )

More from ecancer